A clear siloing of AI technology is developing, and without upskilling India won’t be able to break the US-China duopoly. Only a globally competent labour force will benefit from the free movement regime in services in our trade negotiations. Businesses… Read More »There’s no stopping the march of AI. Unveil massive upskilling programmes for our techies
The petition filed by the Hajrat Peer Malik Rehan Mira Saheb Dargah Trust challenged the directive issued by the Deputy Director of Archaeology and Museums, Mumbai on February 1 this year prohibiting illegal animal slaughter in the name of sacrifice… Read More »Won#39;t allow unregulated slaughter of animals: Bombay HC
The biscuit-maker’s stock, which has a ‘buy’ rating from 31 analysts, crossed Rs 5,000 Read More The biscuit-maker’s stock, which has a ‘buy’ rating from 31 analysts, crossed Rs 5,000 The biscuit-maker’s stock, which has a ‘buy’ rating from 31… Read More »Britannia shares reach new milestone; analysts see more than 50% upside
The stock had fallen sharply on June 14 after BSE sold a 4.5 percent stake in CDSL. The stock got a boost as 21 lakh demat accounts were opened in May, which is 33 percent more than those in April… Read More »CDSL bounces back after stake sale by BSE, rise in demat accounts
The salary disparity among top executives of public sector and private sector banks have been a subject of debate for years. Read More The salary disparity among top executives of public sector and private sector banks have been a subject… Read More »Yawning gap: SBI chairman’s Rs 37 lakh salary reignites public vs private banks debate
Ribeiro has pioneered this method over the past decade at the treatment center, which features an open-air space where patients interact with lizards, turtles and a “jacare” — a kind of alligator native to Latin America that is common in… Read More »Snakes as therapy animals: reptiles help heal in Brazil
The stock saw a sharp upmove of 300 percent between March 2020 and July 2021, touching Rs 1,800 as COVID outbreak led to a spike in demand for its main offerings — Ibuprofen, Favipiravir and Gabapentin Read More The stock… Read More »Solara Active Pharma spurts 9% on heavy volumes
Trastuzumab is used in the treatment of a particular type of breast cancer — HER2-positive, and the company markets its version in India under the brand name #39;Trumab#39;. Read More Trastuzumab is used in the treatment of a particular type… Read More »Glenmark Pharma slashes price of breast cancer drug Trastuzumab
In its response, SoftwareOne board, said the offer “materially undervalues” the company and was not in its best interest or that of the majority of its shareholders. Read More In its response, SoftwareOne board, said the offer “materially undervalues” the… Read More »Bain Capital makes $3.2 billion offer for SoftwareOne, board says it#39;s too low
Emkay Global Financial is bullish on Britannia Industries has recommended buy rating on the stock with a target price of Rs 5700 in its research report dated June 14, 2023. Read More Emkay Global Financial is bullish on Britannia Industries… Read More »Buy Britannia Industries; target of Rs 5700: Emkay Global Financial
English 
हिन्दी